全文获取类型
收费全文 | 1479931篇 |
免费 | 110074篇 |
国内免费 | 2590篇 |
专业分类
耳鼻咽喉 | 18756篇 |
儿科学 | 46648篇 |
妇产科学 | 39013篇 |
基础医学 | 217582篇 |
口腔科学 | 38830篇 |
临床医学 | 139585篇 |
内科学 | 292542篇 |
皮肤病学 | 30312篇 |
神经病学 | 122848篇 |
特种医学 | 54063篇 |
外国民族医学 | 277篇 |
外科学 | 211525篇 |
综合类 | 28821篇 |
现状与发展 | 3篇 |
一般理论 | 873篇 |
预防医学 | 123486篇 |
眼科学 | 33873篇 |
药学 | 107193篇 |
13篇 | |
中国医学 | 2327篇 |
肿瘤学 | 84025篇 |
出版年
2021年 | 13969篇 |
2019年 | 14489篇 |
2018年 | 18595篇 |
2017年 | 14146篇 |
2016年 | 15548篇 |
2015年 | 18028篇 |
2014年 | 25342篇 |
2013年 | 37617篇 |
2012年 | 52872篇 |
2011年 | 56072篇 |
2010年 | 32177篇 |
2009年 | 30325篇 |
2008年 | 51893篇 |
2007年 | 55223篇 |
2006年 | 54683篇 |
2005年 | 53954篇 |
2004年 | 51380篇 |
2003年 | 48860篇 |
2002年 | 46950篇 |
2001年 | 57896篇 |
2000年 | 58473篇 |
1999年 | 50115篇 |
1998年 | 16035篇 |
1997年 | 14445篇 |
1996年 | 14531篇 |
1995年 | 13724篇 |
1994年 | 12624篇 |
1993年 | 11791篇 |
1992年 | 39321篇 |
1991年 | 38673篇 |
1990年 | 37333篇 |
1989年 | 36120篇 |
1988年 | 33551篇 |
1987年 | 32881篇 |
1986年 | 31363篇 |
1985年 | 29657篇 |
1984年 | 23010篇 |
1983年 | 20173篇 |
1982年 | 12549篇 |
1979年 | 21593篇 |
1978年 | 16068篇 |
1977年 | 13353篇 |
1976年 | 12374篇 |
1975年 | 13227篇 |
1974年 | 16013篇 |
1973年 | 15710篇 |
1972年 | 14824篇 |
1971年 | 13791篇 |
1970年 | 12997篇 |
1969年 | 12224篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
991.
992.
Introduction – The relative frequencies of different ataxias vary among different ethnic and geographic groups. The aim of this study was to examine patients with cerebellar ataxia and find the occurrence of autosomal dominant and recessive cerebellar ataxias in the population of the southern and eastern parts of Norway and estimate its prevalence.
Materials and methods – Probands were systematically tested for spinocerebellar ataxia 1, 2, 3, 6 and Friedreich's ataxia. A total of 94 patients with ataxia were assessed.
Results – We registered 60 patients from 39 unrelated families with hereditary ataxias. One family with SCA2 (two patients), one family with Friedreich's ataxia (two patients), two patients heterozygote for Friedreich's ataxia and one metabolic ataxia were identified.
Conclusions – We have few Friedreich's ataxia and SCA 1,2,3 and 6 in our population. Prevalence in Oslo County was estimated at 2.2/100,000 for autosomal recessive and 3.0/100,000 for autosomal dominant ataxia, respectively. 相似文献
Materials and methods – Probands were systematically tested for spinocerebellar ataxia 1, 2, 3, 6 and Friedreich's ataxia. A total of 94 patients with ataxia were assessed.
Results – We registered 60 patients from 39 unrelated families with hereditary ataxias. One family with SCA2 (two patients), one family with Friedreich's ataxia (two patients), two patients heterozygote for Friedreich's ataxia and one metabolic ataxia were identified.
Conclusions – We have few Friedreich's ataxia and SCA 1,2,3 and 6 in our population. Prevalence in Oslo County was estimated at 2.2/100,000 for autosomal recessive and 3.0/100,000 for autosomal dominant ataxia, respectively. 相似文献
993.
994.
Understanding the minimum clinically important difference: a review of concepts and methods. 总被引:2,自引:0,他引:2
Anne G Copay Brian R Subach Steven D Glassman David W Polly Thomas C Schuler 《The spine journal》2007,7(5):541-546
BACKGROUND CONTEXT: The effectiveness of spinal surgery as a treatment option is currently evaluated through the assessment of patient-reported outcomes (PROs). The minimum clinically important difference (MCID) represents the smallest improvement considered worthwhile by a patient. The concept of an MCID is offered as the new standard for determining effectiveness of a given treatment and describing patient satisfaction in reference to that treatment. PURPOSE: Our goal is to review the various definitions of MCID and the methods available to determine MCID. STUDY DESIGN: The primary means of determining the MCID for a specific treatment are divided into anchor-based and distribution-based methods. Each method is further subdivided and examined in detail. METHODS: The overall limitations of the MCID concept are first identified. The basic assumptions, statistical biases, and shortcomings of each method are examined in detail. RESULTS: Each method of determining the MCID has specific shortcomings. Three general limitations in the accurate determination of an MCID have been identified: the multiplicity of MCID determinations, the loss of the patient's perspective, and the relationship between pretreatment baseline and posttreatment change scores. CONCLUSIONS: An ideal means of determining the MCID for a given intervention is yet to be determined. It is possible to develop a useful method provided that the assumptions and methodology are initially declared. Our efforts toward the establishment of a MCID will rely on the establishment of specific external criteria based on the symptoms of the patient and treatment intervention being evaluated. 相似文献
995.
A K Burroughs L Marelli E Cholongitas P Manousou K Rolles V Karam V Delvart R Adam C Sabin 《Liver transplantation》2007,13(6):935-6; author reply 937
996.
Contin Educ Anaesth Crit 相似文献
997.
Quantification of Basal and Stimulated ROS Levels as Predictors of Islet Potency and Function 总被引:2,自引:0,他引:2
B. Armann M. S. Hanson E. Hatch A. Steffen L. A. Fernandez 《American journal of transplantation》2007,7(1):38-47
We have developed a luminol-based assay using intact islets, which allows for quantification of reactive oxygen species (ROS). In addition, an index capable of characterizing metabolic and mitochondrial integrity prior to transplantation was created based on the capacity of islets to respond to high glucose and rotenone (mitochondrial respiratory chain complex I inhibitor) by production of ROS. To validate this assay, lipid peroxidation and antioxidative defense capacity were evaluated by detection of malondialdehyde (MDA) levels and glutathione peroxidase activity (GPx), respectively. Also, flow cytometric analyses of ROS (dihydroethidine), apoptosis (Annexin V, active caspases), necrosis (Topro3), and mitochondrial membrane potential (JC-1) were done in parallel to correlate with changes in luminol-measured ROS. ATP/ADP ratios were quantified by HPLC and the predictive value of ROS measurement on islet functional potency was correlated with capacity to reverse diabetes in a streptozotocin-induced diabetic NOD.scid mouse model as well as in human transplant recipients. Our data demonstrate that levels of ROS in islets correlate with the percentage of apoptotic cells and their functional potency in vivo. The ROS indices following glucose and rotenone exposure are indicative of metabolic potency and mitochondrial integrity and can be used as surrogate markers to evaluate the quality of islets prior to transplantation. 相似文献
998.
999.
Trauma und Berufskrankheit - Nur 0,4–1% aller Frakturen betreffen die Skapula, die meisten davon können erfolgreich konservativ funktionell behandelt werden. Zur Identifikation der... 相似文献
1000.
G. Burastero N. Sessarego G. Grappiolo C. Castellazzo S. Castello A. Pitto G. Cittadini M. Podesta G. Bovio M. Peresi E. Fulcheri F. Frassoni L. Spotorno 《Journal of orthopaedics and traumatology》2007,8(1):49-54
Mesenchymal stem cells (MSC), easily culture-expanded from bone marrow, can significantly enhance bone defect healing. Several
proteins, such as the bone morphogenetic proteins (BMPs) and in particular BMP-7, are involved in bone formation in vitro
and in vivo. In this preclinical study, we evaluated if the association of human MSC (hMSC) with BMP-7 had synergic action
on bone healing. Rat femoral defects (n=12) were treated with: autoclaved bone and mononucleated cells (MNC) as control group
G1; bone and hMSC, group G2; bone with BMP-7, group G3; bone and hMSC plus BMP-7, group G4. Defect regeneration was evaluated
with plain radiographs after 2, 4, 8 and 12 weeks and with histological analysis. We observed organized trabeculae bridging
between the osteotomic ends of the host bone in rats treated with the association of hMSC and rhBMP-7. These trabeculae, formed
by a core of devitalized tissue surrounded by osteoblasts, osteocytes and osteoclasts, were continuous with a cortical-like
structure of bony tissue. Such new bone formation of the group treated with the association of hMSC and rhBMP-7 (G4) was clearly
superior compared to rats treated with rhBMP-7 (G2) or hMSC (G3) alone, as shown by radiographic analysis and histological
study. The present study suggests that the association of hMSC and BMP-7 is more effective than hMSC or BMP-7 alone in the
healing of femoral defects in rats. Further studies with larger samples are required to confirm these results and to evaluate
the best dosage. 相似文献